The sociology of cognitive enhancement: Medicalisation and beyond

References

• Abraham, J. (2009). The pharmaceutical industry, the state and the NHS. In J. Gabe & M. Calnan (Eds.), The new sociology of the health service. London: Routledge.
   Google Scholar
• Abraham, J. (2010). Pharmaceuticalisation of society in context: Theoretical, empirical and health dimensions. Sociology, 44, 603–622.
   Google Scholar
• Armstrong, D. (1995). The rise of surveillance medicine. Sociology of Health and Illness, 17, 393–404.
   Google Scholar
• Busfield, J. (2010). ‘A pill for every ill’: Explaining the expansion in medicine use. Social Science & Medicine, 70, 931–941.
   Google Scholar
• Caplan, A., & Elliott, C. (2004). Is it ethical to use enhancement technologies to make us better than well? PLoS Medicine, 1(3), 172–175.
   Google Scholar
• Clarke, A., Fishman, J., Fosket, J. R., Mamo, L., & Shim, J. (2003). Biomedicalization: Technoscientific transformations of health, illness and US biomedicine. American Sociological Review, 68, 161–194.
   Google Scholar
• Clarke, A. E., & Shim, J. K. (2011). Medicalisation and biomedicalisation revisited: Technoscience and transformations of health, illness and American medicine. In B. A. Pescosolido, J. Martin, J. D. McLeod, & A. Rogers (Eds.), Handbook of the sociology of health, illness and healing (pp. 173–199). New York: Springer.
   Google Scholar
• Conrad, P. (2007). The medicalisation of society. Baltimore, MD: Johns Hopkins University Press.
   Google Scholar
• Conrad, P., & Potter, D. (2004). Human growth hormone and the temptations of biomedical enhancement. Sociology of Health and Illness, 26, 184–215.
   Google Scholar
• Coveney, C. M. (2010). Awakening expectations: Exploring social and ethical issues surrounding the medical and non-medical uses of cognition enhancing drugs in the UK. PhD thesis, University of Nottingham, Nottingham, UK.
   Google Scholar
• Coveney, C. M. (2011). Exploring modafinil use in social context. In M. D. Pickersgill & I. van Keulen, Sociological reflections on neuroscience. Bingley, UK: Emerald.
   Google Scholar
• Coveney, C. M., Nerlich, B., & Martin, P. (2009). Modafinil in the media: Metaphors, medicalisation and the body. Social Science & Medicine, 68(3), 487–495.
   Google Scholar
• Daniels, N. (2000). Normal functioning and the treatment – Enhancement distinction. Cambridge Quarterly of Healthcare Ethics, 9, 309–322.
   Google Scholar
• De Jongh, R., Bolt, I., Schermer, M., & Olivier, B. (2008). Botox for the brain: Enhancement of cognition, mood and pro-behavior and blunting of unwanted memories. Neuroscience and Biobehavioral Reviews, 32(4), 760–776.
   Google Scholar
• Dees, R. H. (2004). Slippery slopes, wonder drugs, and cosmetic neurology. The neuroethics of enhancement. Neurology, 63, 951–952.
   Google Scholar
• Department of Trade and Industry. (2005). FORESIGHT: Drug futures 2025? Horizon scan (DTI/Pub 7914/3k/07/05/NP. URN 05/1186). London: Office of Science and Technology, Her Majesty’s Stationery Office.
   Google Scholar
• Esposito, M. F. (2005). Ethical implications of pharmacological enhancement of mood and cognition. Penn Bioethics Journal, 1(1), 1–4.
   Google Scholar
• Farah, M. (2002). Emerging ethical issues in neuroscience. Nature Neuroscience, 5(11), 1123–1128.
   Google Scholar
• Farah, M., Illes, J., Cook-Deegan, R., Gardner, H., Kandel, E., King, P., et al. (2004). Neurocognitive enhancement: What can we do and what should we do? Nature Reviews Neuroscience, 5, 421–425.
   Google Scholar
• Fishman, J. R. (2010). The making of Viagra. In A. E. Clarke, L. Mamo, J. R. Fosket, J. R. Fishman, & J. K. Shim (Eds.), Biomedicalisation: Technoscience, health and illness in the U.S. (pp. 289–306). London: Duke University Press.
   Google Scholar
• Fox, N. J., & Ward, K. J. (2009). Pharma in the bedroom … and the kitchen. The pharmaceuticalisation of daily life. In S. J. Williams, J. Gabe, & P. Davis (Eds.), Pharmaceuticals and society. Oxford, UK: Blackwell.
   Google Scholar
• Fox, N. J., Ward, K. J., & O’Rourke, A. J. (2005). The ‘expert patient’: Empowerment or medical dominance? The case of weight loss, phamaceutical drugs and the Internet. Social Science & Medicine, 60, 1299–1309.
   Google Scholar
• Fukuyama, F. (2002). Our posthuman future. London: Profile Books.
   Google Scholar
• Fullagar, S. (2009). Negotiating the neurochemical self: Anti-depressant consumption in women’s recovery from depression. Health, 13, 389–406.
   Google Scholar
• Furedi, F. (2006). The end of professional dominance. Society, 43, 21–29.
   Google Scholar
• Greely, H., Sahakian, B., Harris, J., Kessler, R. C., Gazzinga, M., Campbell, P., et al. (2008). Towards responsible use of cognitive-enhancing drugs by the healthy. Nature, 456, 702–705.
   Google Scholar
• Hall, S. (2006). Size matters: How height affects the health, happiness and success of boys – And the men they become. New York: Houghton Mifflin.
   Google Scholar
• Herzberg, D. (2009). Happy pills in America: From Miltown to Prozac. Baltimore, MD: The Johns Hopkins University Press.
   Google Scholar
• Hyman, S. E. (2006). Improving our brains? BioSocieties, 1, 103–111.
   Google Scholar
• Lakoff, A. (2005). Pharmaceutical reason: Knowledge and value in global psychiatry. Cambridge, UK: Cambridge University Press.
   Google Scholar
• Maher, B. (2008). Poll results: Look who’s doping. Nature, 452(7188), 674–675.
   Google Scholar
• Maines, R. (2001). The technology of orgasm: ‘Hysteria’, the vibrator, and women’s sexual satisfaction. Baltimore, MD: Johns Hopkins University Press.
   Google Scholar
• Mamo, L. (2010). ‘Fertility Inc.’ In A. E. Clarke, L. Mamo, J. R. Fosket, J. R. Fishman, & J. K. Shim (Eds.), Biomedicalisation: Technoscience, health and illness in the U.S. (pp. 173–196). London: Duke University Press.
   Google Scholar
• Martin, E. (1994). Flexible bodies. Boston: Beacon.
   Google Scholar
• Martin, P., Pickersgill, M., Coveney, C. M., & Williams, S. J (2011). Pharmaceutical cognitive enhancement: Interrogating the ethics, addressing the issues. In F. Fenter (Ed.), Augmented cognition. Lausanne, Switzerland: EPFL Press.
   Google Scholar
• Miller, P., & Wilsdon, J. (Eds.) (2006). Better humans? London: Demos.
   Google Scholar
• Morrison, M. (2008, Winter). Beyond the perils and promise of human enhancement: The social shaping of enhancement technologies (technology and humanity). eSharp, 12, 1–24.
   Google Scholar
• Moynihan, R., Health, I., & Henry, D. (2002). Selling sickness: The pharmaceutical industry and disease mongering. British Medical Journal, 324, 886–890.
   Google Scholar
• Müller, U., Steffenhagen, N., Regenthal, R., & Bublak P. (2004). Effects of modafinil on working memory processes in humans. Psychopharmacology, 117, 161–169.
   Google Scholar
• Parens, E. (Ed.) (1998). Enhancing human traits: Ethical and social implications. Washington, DC: Georgetown University Press.
   Google Scholar
• Parliamentary Office of Science and Technology [POST]. (2007). Postnote – Better brains, June Number 285. London: Parliamentary Office of Science and Technology.
   Google Scholar
• President’s Council on Bioethics. (2002). Distinguishing therapy and enhancement, staff working paper 7, April 2002. Washington, DC: President’s Council on Bioethics.
   Google Scholar
• Quednow, B. (2010). Ethics of neuroenhancement: A phantom debate. Biosocieties, 5(1), 153–156.
   Google Scholar
• Rasmussen, N. (2008). On speed: The many lives of amphetamines. New York: New York University Press.
   Google Scholar
• Robitaille, M. (2008). Optimization of human capacities and the representation of the nanoscale body. International Journal of Disability, Community & Rehabilitation, 8(2). Retrieved from http://www.ijdcr.ca/VOL08_02/articles/robitaille.shtml
   Google Scholar
• Rose, N. (1996). Inventing our selves. New York: Cambridge University Press.
   Google Scholar
• Rose, N. (1999). Governing the soul: The shaping of the private self (2nd ed.). London: Free Association Books.
   Google Scholar
• Rose, N. (2007). The politics of life itself. Princeton, NJ: Princeton University Press.
   Google Scholar
• Sahakian, B., & Morein-Zamir, S. (2007). Professor’s little helper. Nature, 450(7173), 1157–1159.
   Google Scholar
• Schermer, M., Bolt, I., De Jongh, R., & Olivier, B. (2009). The future of psychopharmacological enhancements: Expectations and policies. Neuroethics, 2(2), 75–87.
   Google Scholar
• Schwartz-Cowen, R. (1985). The industrial revolution in the home. In D. MacKenzie, & J. Wajcman (Eds.), The social shaping of technology. Milton Keynes, UK: Open University Press.
   Google Scholar
• Synofzik, M. (2009). Ethically justified, clinically applicable criteria for physician decision-making in psychopharmacological enhancement. Neuroethics, 2(2), 89–102.
   Google Scholar
• Tannsjo, T. (2009). Ought we to enhance our cognitive capacities? Bioethics, 23(7), 421–432.
   Google Scholar
• Teter, C. J., McCabe, S. E., LaGrange, K., Cranford, J. A., & Boyd, C. J. (2006). Illicit use of specific prescription stimulants among college students: Prevalence, motives and routes of administration. Pharmacotherapy, 26, 1501–1510.
   Google Scholar
• Turner, D., Robbins, T. W., Clark, L., Aron, A. R., Dowson, J., & Sahakian, B. (2003). Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology, 165, 260–269.
   Google Scholar
• Williams, S. J. (2010). New developments in neuroscience and medical sociology. In W. C. Cockerham (Ed.), The new Blackwell companion to medical sociology. Oxford, UK: Wiley-Blackwell.
   Google Scholar
• Williams, S. J., Gabe, J., & Davis, P (Eds.) (2009). Pharmaceuticals and society. Oxford, UK: Wiley-Blackwell.
   Google Scholar
• Williams, S. J., Katz, S., & Martin, P. (2011). Beyond medicalisation? Memory, medicine and the brain. In M. D. Pickersgill & I. Van Keulen (Eds.), Sociological reflections on the neurosciences. Bingley, UK: Emerald.
   Google Scholar
• Williams, S. J., Martin, P., & Gabe, J. (2011). The pharmaceuticalisation of society? A framework for analysis. Sociology of Health and Illness, 33(5), 710–725.
   Google Scholar
• Williams, S. J., Seale, C., Boden, S., Lowe, P., & Steinberg, D. (2008). Waking up to sleepiness: Modafinil, the media and the pharmaceuticalisation of everyday/night life. Sociology of Health and Illness, 30, 839–855.
   Google Scholar
• Wolpe, P. (2002). Treatment, enhancement and the ethics of neurotherapeutics. Brain and Cognition, 50, 387–395.
   Google Scholar